🟢 AstraZeneca is trading 3.09% up on October 29, 2026, as investors rotate toward defensive stocks

AstraZeneca is trading at £13,158.00, up 3.09%, with healthcare-sector strength supporting the rise.

• Investors are responding to strong Merck and Eli Lilly earnings and rotating toward defensive stocks.
• AstraZeneca is trading ahead of its Q3 results, scheduled for October 30.
• No separate AstraZeneca announcement on October 29 was identified; the available report attributes the move to sector support, not a new company-specific catalyst.